GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Novartis India Ltd

Evonile Pharma Appoints Gagan Sharma as Senior Management Personnel

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 26 Oct 2026, 04:51 PM IST  ·  BSE ID: 2e366042-655c-46e9-95fc-ee45f567b0d7
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has officially named Gagan Sharma to a senior leadership position, effective immediately.
🤖 AI Summary
  • Evonile Pharma appoints Gagan Sharma as Senior Management Personnel.
  • Sharma's designation is President – Specialty Business.
  • Appointment effective October 26, 2026, with extensive industry experience.
  • This follows Novartis AG's significant share sale to ChrysCapital.
🏢 How This Affects the Company
📈
Business Impact
The appointment signifies a strengthening of the senior leadership team within Evonile Pharma, potentially impacting strategic direction in the specialty business segment.
💰
Financial Impact
No immediate financial impact is discernible from this management appointment disclosure.
⚙️
Operational Impact
Mr. Sharma's extensive experience is intended to enhance operational effectiveness in the specialty business unit.
⚠️
Risk Impact
No new risks are immediately apparent; the appointment aims to leverage existing expertise.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this management appointment.
👤
Who Is Affected
All shareholders are indirectly affected as senior management changes can influence company strategy and performance.
🔍
Management Signal
This appointment signals management's focus on leveraging experienced leadership for business growth and stability.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Future quarterly results for performance insights.
Announcements regarding strategic initiatives led by new SMP.
Company's next annual report for leadership commentary.
LOW RISK Standard management appointment with no inherent operational or financial risks disclosed.
💡 Investor Takeaway
Evonile Pharma has designated Gagan Sharma, President – Specialty Business, as Senior Management Personnel effective October 26, 2026. Mr. Sharma has over 30 years of industry experience.
📅 Company Track Record
Evonile Pharma Limited was formerly known as Novartis India Limited. In July 2026, Novartis AG sold 17,450,680 shares to ChrysCapital, leading to board changes.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
Who has been appointed as Senior Management Personnel at Evonile Pharma?
Mr. Gagan Sharma has been appointed as Senior Management Personnel at Evonile Pharma.
What is Gagan Sharma's role at Evonile Pharma?
Mr. Gagan Sharma's designation is President – Specialty Business.
When is Gagan Sharma's appointment as Senior Management Personnel effective?
The appointment of Mr. Gagan Sharma as Senior Management Personnel is effective October 26, 2026.
What experience does Gagan Sharma bring to Evonile Pharma?
Mr. Gagan Sharma brings over 30 years of extensive experience in the pharmaceutical industry.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.